N/A
N=22,349
Systems Analysis and Improvement Approach for the Hypertension Care Cascade
HIV/AIDS · Hypertension
Bottom Line
View on ClinicalTrials.gov: NCT04088656 ↗Enrolled (actual)
22,349
Serious AEs
0.0%
Results posted
Nov 2024
Primary outcome: Primary: Controlled Hypertension — 3; 315; 37; 1 Participants
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Systems Analysis and Improvement Approach for Hypertension Screening and Treatment Optimization (Other)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- University of Washington
- Primary completion
- Sep 2023
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Controlled Hypertension |
3; 315; 37; 1; 82; 14 | — |
| SECONDARY Blood Pressure Screening |
4275; 20359; 2182; 3351; 17882; 2556 | — |
| SECONDARY Hypertension Diagnosis |
318; 2247; 244; 288; 2442; 404 | — |
| SECONDARY Hypertension Treatment Prescription |
221; 1678; 177; 175; 1698; 256 | — |
| SECONDARY Hypertension Medication Pick up |
74; 1447; 157; 52; 1430; 161 | — |
Summary
As undiagnosed and untreated hypertension is one of the largest drivers of cardiovascular disease in sub-Saharan Africa approaches are needed to optimize the hypertension care cascade. The HIV treatment platform in low and middle income countries provides a robust, scalable foundation to address other chronic care priorities, such as hypertension. This proposal will evaluate an evidence-based intervention designed to improve chronic care services (the Systems Analysis and Improvement Approach (SAIA)) for hypertension detection and management in people living with HIV, and will build evidence on how to achieve rapid, sustainable and scalable improvements in services that can dramatically improve population health in resource-limited countries.
Eligibility Criteria
Inclusion Criteria
- (A1) Frontline Health Workers / Health Facility Managers currently working in outpatient, emergency or related (pharmacy, laboratory) services at one of the study clinics in Manica and Sofala provinces, Mozambique; (A2) District Health Supervisors currently employed in a study district in Manica and Sofala provinces, Mozambique regularly engaged in service provision or management of HIV-infected and/or hypertensive populations; and (A3) Clinical Experts currently working in Mozambique in the clinical delivery of HIV and/or hypertension care and treatment or (B1) People Living with HIV >14 years old (B2) access HIV care and treatment services via outpatient/emergency services in study clinics. >14 years is being used as the current Ministry of Health forms only use the age bounds of 14y and there is significant concern by the Mozambican Ministry of Health to minimize additional data collection when not absolutely necessary.
Exclusion Criteria
- (A1) not currently working as a Frontline Health Worker/Health Facility Manager at a participating study facility or (A2) not currently working as a District Health Supervisor in a participating district or (A3) not currently working in Mozambique in the clinical delivery of HIV and/or hypertension care and treatment or (B1) HIV-negative or of unknown status or (B2) <15 years old or age not recorded, (B3) or pregnant or postpartum.
Data sourced from ClinicalTrials.gov (NCT04088656). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.